Portal de Periódicos da CAPES

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

2012; Oxford University Press; Volume: 55; Issue: 5 Linguagem: Inglês

10.1093/cid/cis500

1537-6591

Juan Berenguer, Elisa Boucourt Rodríguez, Pilar Miralles, M. A. von Wichmann, José López-Aldeguer, Josep Mallolas, Marı́a José Galindo, Eva Van den Eynde, María Jesús Téllez, Carmen Quereda, Antoni Jou, José Sanz, Carlos Barrós, Ignacio de los Santos, Federico Pulido, Josep M. Guardiola, Enrique Ortega, Rafael Rubio, J.J. Jusdado, Marisa Montes, G. Gaspar, Herminia Esteban, José M. Bellón, Juan González‐García,

Hepatitis B Virus Studies

Background. Sustained virological response (SVR) after therapy with interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). We assessed the effect of SVR on HIV progression and mortality not related to liver disease.